GeneDx Holdings Corp. Cash And Cash Equivalents At Carrying Value

• GeneDx Holdings Corp. showed an increase of +23.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from GeneDx Holdings Corp.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
• XBRL data for this metric is available from 2020 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2020 to 2025), GeneDx Holdings Corp.'s Cash And Cash Equivalents At Carrying Value has declined by 2.9%.
• Historical annual values: Fiscal year 2025: $105.00 million | Fiscal year 2024: $85.21 million | Fiscal year 2023: $99.68 million | Fiscal year 2022: $123.93 million | Fiscal year 2021: $400.57 million | Fiscal year 2021: $461.28 million | Fiscal year 2021: $26.50 million | Fiscal year 2021: $58.65 million | Fiscal year 2020: $108.13 million.
• Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: June 24, 2026